Shanthi Rexaline

Shanthi is a contributor to and works as a Staff Writer with Benzinga. Equipped with a Bachelor’s degree in Agriculture and an MBA with specialization in finance and marketing, she has about two decades of experience in financial reporting and analysis, and specializes in the biopharma and EV sectors.

Recent Articles

7 Cheap Biotech Stocks to Buy Now

These cheap biotech stocks to buy offer investors a way to get ready for the inevitable comeback in the biopharmaceutical sector.

What Is a Reverse Stock Split and How Does It Work?

Reverse stock splits are not that common and often are associated with some trouble brewing at the company. Therefore, one must do a thorough study before deciding what to do what with the stock of a company that just announced a reverse split.

7 Surprising Meme Stocks to Buy and Hold in 2022

All meme stocks may not be sound investment options. A close scrutiny of these stocks can help to zero in on investment-worthy candidates from among these stocks.

8 Semiconductor Stocks to Buy on the Dip

Once the bear market runs its course, semiconductor stocks could lead the market recovery and here are a few bargain buys offering biggest upside potential.

7 Biotech Stocks to Buy for Q3

These biotech stocks could be good buys due for a few reasons, including great R&D pipelines and treatments with promising market potential.